Natco Pharma launches generic version of Tenofovir Alafenamide in India
Natco Pharma has launched a generic version of Tenofovir Alafenamide, which is used to treat chronic Hepatitis B in India. The company is one of […]
New Launches
Glenmark Pharma launches Kwitz – to quit smoking habit
Glenmark Pharmaceuticals has launched Kwitz, a medically approved nicotine replacement therapy for smokers. The Nicotine gum will be available in two variants. Kwitz 2mg will […]
DRL launches Clofarbine injection in US Markets
Dr. Reddy s Laboratories Ltd has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar (clofarabine) Injection in the United States market. The company […]
Glenmark Pharma launches Apermilast drug for Psoriasis
Glenmark Pharmaceuticals has launched Apremilast, the first advanced oral systemic treatment for Psoriasis in India. The drug is phosphodiesterase 4 (PDE4) inhibitor indicated for the […]
DRL launches nystatin and triamcinolone acetonide cream in USA
Dr Reddy’s Laboratories Ltd has launched nystatin and triamcinolone acetonide cream USP, in the United States market which has been approved by the USFDA. The […]
Cipla to launch Entecavir tablet in USA
Cipla has received final USFDA approval to market Entecavir tablets used for treatment of Hepatitis B infection. The tablets are generic versions of Bristol-Myers Suibb’s […]
DRL launches Nitrostat tablets in US
Dr Reddy’s Laboratories has launched Nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in the US. The drug which is […]
Panacea Biotec launches Cabapan (Cabazitaxel Injection) in India
Panacea Biotec has launched indigenously developed high quality oncology product, CABAPAN (Cabazitaxel Injection), for treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC). The company will […]
Sanofi Pasteur launches vaccine research for Zika virus
Sanofi Pasteur, the vaccines division of Sanofi, has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease. The […]
Torrent Pharma launches Adalimumab in India under the brand “Adfrar”
Torrent Pharmaceuticals has launched bio similar Adalimumab, used for the treatment of auto immune disorders in India its under the brand name ‘Adfrar’. The company’s […]